Chemie Linz Aktiengesellschaft

Crinos Industria Farmacobiologica S.p.a.

Karsten Schror

Dieter Binder

Franz Rovenszky

Hubert P Ferber

Franzpeter Bracht

Cathepsin G-inhibiting aptamers comprising oligonucleotides selected from the group consisting of the consensus sequences: ##STR1## wherein N represents nucleotides and the figures represent the number of possible nucleotides at that site; said cathepsin G-inhibiting aptamers are suggested as medicament.

Cathepsin G-inhibiting aptamers

The invention relates to new nitrogen-arylmethoxy-thiophene derivatives of the formula I ##STR1## wherein the R--CH.sub.2 --O-group is in position 4 or 5 of the thiophene ring, R denotes a 2-pyridinyl- or 2-quinolinyl group and R.sub.1 denotes a --COO-lower alkyl-, --CO--(CH.sub.2)n--CH.sub.3 or --CH(OH)--(CH.sub.2).sub.n --CH.sub.3 group, wherein n represents an integer from 2 to 6, and their hydrates and/or their pharmaceutically acceptable acid addition salts, a process for their preparation and pharmaceutical products containing these compounds. The new compounds and their salts have useful pharmacological properties. They can be used as active compounds for medicaments for the treatment and prevention of diseases, caused by a disturbance in arachidonic acid metabolism.

Growing community of inventors

Frechen-Konigsdorf, Germany

Karsten Schror